Search
04/02/2025
Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
Bastos-Oreiro, M, Iacoboni, G, Garcés, VN, Caballero, AC, Martínez, N, Delgado, J, Balaguer, A, Kwon, M, de Villambrosia, S, Hernani, R, Jimenez-Ubieto, A, Bailen, R, Zaberio, I, García-Sancho, A, Barba, P. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. Hemasphere. 2025; 9(2)DOI:10.1002/hem3.70077. PMID:39906687. IF:14.600(Q1/1D).
04/02/2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Cortellini, A, Brunetti, L, Di Fazio, GR, Garbo, E, Pinato, DJ, Naidoo, J, Katz, A, Loza, M, Neal, JW, Genova, C, Gettinger, S, Kim, SY, Jayakrishnan, R, El Zarif, T, Russano, M, Pecci, F, Di Federico, A, Awad, M, Alessi, J, Montrone, M, Owen, DH, Signorelli, D, Fidler, MJ, Li, MJ, Camerini, A, De Giglio, A, Young, L, Vincenzi, B, Metro, G, Passiglia, F, Yendamuri, S, Guida, A, Ghidini, M, Awosika, NO, Napolitano, A, Fulgenzi, CAM, Grisanti, S, Grossi, F, D'Incecco, A, Josephides, E, Van Hemelrijck, M, Russo, A, Gelibter, A, Spinelli, G, Verrico, M, Tomasik, B, Giusti, R, Newsom-Davis, T, Bria, E, Sebastian, M, Rost, M, Forster, M, Mukherjee, U, Landi, L, Mazzoni, F, Aujayeb, A, Dupont, M, Curioni-Fontecedro, A, Chiari, R, Pantano, F, Morabito, A, Leonetti, A, Friedlaender, A, Addeo, A, Zoratto, F, De Tursi, M, Cantini, L, Roca, E, Mountzios, G, Della Gravara, L, Kalvapudi, S, Inno, A, Bironzo, P, Barros, RD, O'Reilly, D, Bell, J, Karapanagiotou, E, Monnet, I, Baena, J, Macerelli, M, Majem, M, Agustoni, F, Cortinovis, DL, Tonini, G, Minuti, G, Bennati, C, Mezquita, L, Gorría, T, Servetto, A, Beninato, T, Lo Russo, G, Rogado, J, Moliner, L, Biello, F, Nana, FA, Dingemans, AM, Aerts, JGJ, Ferrara, R, Torri, V, Abu Hejleh, T, Takada, K, Naqash, AR, Garassino, M, Peters, S, Wakelee, H, Nassar, AH, Ricciuti, B. Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. Journal for ImmunoTherapy of Cancer. 2025; 13(2)DOI:10.1136/jitc-2024-010674. PMID:39904562. IF:10.600(Q1/1D).
03/02/2025
Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
Puig, L. Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljaf003. PMID:39761694. IF:9.600(Q1/1D).
03/02/2025
Rapid Quantitative Assessment of Muscle Sodium Dynamics After Exercise Using 23Na-MRI in Dysferlinopathy and Healthy Controls
Neal, MA, Bolano-Diaz, CF, Richardson, M, Michell-Sodhi, J, Muni-Lofra, R, James, MK, Hollingsworth, KG, Hilsden, H, Wilson, I, Blamire, AM, Straub, V, Thelwall, PE, Diaz-Manera, J. Rapid Quantitative Assessment of Muscle Sodium Dynamics After Exercise Using 23Na-MRI in Dysferlinopathy and Healthy Controls. Journal of Cachexia Sarcopenia and Muscle. 2025; 16(1)DOI:10.1002/jcsm.13709. PMID:39900102. IF:9.100(Q1/1D).
01/02/2025
Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year
Puig, N, Camps-Renom, P, Hermansson, M, Aguilera-Simón, A, Marín, R, Bautista, O, Rotllan, N, Blanco-Sanroman, N, Domine, MC, Öörni, K, Sánchez-Quesada, JL, Benitez, S. Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year. JOURNAL OF LIPID RESEARCH. 2025; 66(2)DOI:10.1016/j.jlr.2024.100739. PMID:39746448. IF:4.100(Q2/4D).
01/02/2025
Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective
Pérez-Pérez, J, García-López, S, Valle, TF, Painous, C, Querol-Pascual, MR, Ruiz, PJG, Diago, EB, Delgado, EC, Pastor, BV, Villaplana, MCP, Santana, IM, Estrada, MB, Garride, MC, Ribera, PM, Alvarez, C, Maurino, J, de Prado, A, López-Sendón, JL. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00655-0. PMID:39370480. IF:4.800(Q1/2D).
01/02/2025
Sex Differences in Parkinson's Disease: A Narrative Review
Cattaneo, C, Pagonabarraga, J. Sex Differences in Parkinson's Disease: A Narrative Review. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00687-6. PMID:39630386. IF:4.800(Q1/2D).
01/02/2025
MCC950 Reduces the Anxiodepressive-like Behaviors and Memory Deficits Related to Paclitaxel-Induced Peripheral Neuropathy in Mice
Martínez-Martel, I, Negrini-Ferrari, SE, Pol, O. MCC950 Reduces the Anxiodepressive-like Behaviors and Memory Deficits Related to Paclitaxel-Induced Peripheral Neuropathy in Mice. Antioxidants. 2025; 14(2)DOI:10.3390/antiox14020143. PMID:40002330. IF:6.600(Q1/1D).
01/02/2025
Mapping punishment avoidance learning deficits in non-suicidal self-injury in young adults with and without borderline personality disorder: An fMRI study
Nicolaou, S, Pascual, JC, Soler, J, Ortega, G, Marco-Pallarés, J, Vega, D. Mapping punishment avoidance learning deficits in non-suicidal self-injury in young adults with and without borderline personality disorder: An fMRI study. JOURNAL OF AFFECTIVE DISORDERS. 2025; 370DOI:10.1016/j.jad.2024.11.026. PMID:39542117. IF:4.900(Q1/2D).
01/02/2025
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
Guillén, N, Contador, J, Buongiorno, M, Alvarez, I, Culell, N, Alcolea, D, Lleó, A, Fortea, J, Piñol-Ripoll, G, Carnes-Vendrell, A, Ispierto, ML, Vilas, D, Puig-Pijoan, A, Fernández-Lebrero, A, Balasa, M, Sánchez-Valle, R, Lladó, A. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(1)DOI:10.1007/s00406-023-01701-y. PMID:37898567. IF:3.700(Q1/3D).
01/02/2025
Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis
Dols-Icardo, O, Carbayo, A, Jericó, I, Blasco-Martínez, O, Alvarez-Sánchez, E, Pérez, MAL, Bernal, S, Rodríguez-Santiago, B, Cusco, I, Turon-Sans, J, Cabezas-Torres, M, Caballero-Avila, M, Vesperinas, A, Llansó, L, Pagola-Lorz, I, Torné, L, Valle-Tamayo, N, Muñoz, L, Rubio-Guerra, S, Illán-Gala, I, Cortés-Vicente, E, Gelpi, E, Rojas-García, R. Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(2)DOI:10.1136/jnnp-2024-333834. PMID:38960585. IF:7.500(Q1/1D).
01/02/2025
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Torres, VE, Ahn, C, Barten, TRM, Brosnahan, G, Cadnapaphornchai, MA, Chapman, AB, Cornec-Le Gall, E, Drenth, JPH, Gansevoort, RT, Harris, PC, Harris, T, Horie, S, Liebau, MC, Liew, M, Mallett, AJ, Mei, CL, Mekahli, D, Odland, D, Ong, ACM, Onuchic, LF, Pei, YPC, Perrone, RD, Rangan, GK, Rayner, B, Torra, R, Balk, EM, Gordon, CE, Earley, A, Mustafa, RA, Devuyst, O. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. KIDNEY INTERNATIONAL. 2025; 107(2)DOI:10.1016/j.kint.2024.07.010. PMID:39848746. IF:12.600(Q1/1D).
01/02/2025
Short-term exposure to desert dust and sandstorms and all-cause and cause-specific mortality and morbidity: A systematic review and meta-analysis
Tobías, A, Querol, X, Roqué, M, Lwin, KS, Yuan, L, Ith, S, Wai, HZ, Chua, PL, Solá, I, Renzi, M, Stafoggia, M, Hashizume, M. Short-term exposure to desert dust and sandstorms and all-cause and cause-specific mortality and morbidity: A systematic review and meta-analysis. ENVIRONMENT INTERNATIONAL. 2025; 196DOI:10.1016/j.envint.2025.109277. PMID:39889591. IF:9.700(Q1/1D).
01/02/2025
Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes
Rives, J, Gil-Millan, P, Viladés, D, García-Osuna, A, Genua, I, Miñambres, I, Grau-Agramunt, M, Gich, I, Puig, N, Benitez, S, Julve, J, Pérez, A, Sánchez-Quesada, JL. Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes. Journal of Clinical Medicine. 2025; 14(3)DOI:10.3390/jcm14030862. PMID:39941533. IF:2.900(Q1/2D).
01/02/2025
Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment
de la Torre-Pérez, L, Santero, M, Nieto-Gutierrez, W, Giesen, C, Nardin, A, Cosma, C, Pires, PS, Guida, A, Simonini, M, Lazo, CQ, Xie, F, Alonso-Coello, P. Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2025; 178DOI:10.1016/j.jclinepi.2024.111621. PMID:39638078. IF:5.200(Q1/1D).
01/02/2025
Genicular artery embolization for knee osteoarthritis: a systematic review with meta-analysis and cost-analysis
Hernández-Yumar, A, González-Hernández, Y, del Pino-Sedeño, T, Valcárcel-Nazco, C, de Armas-Castellano, A, Herrera-Ramos, E, Navarro, JP, Carmona-Rodríguez, M, Rojas-Reyes, MX, Trujillo-Martín, MM. Genicular artery embolization for knee osteoarthritis: a systematic review with meta-analysis and cost-analysis. Gaceta Sanitaria. 2025; 39DOI:10.1016/j.gaceta.2025.102459. PMID:39965462. IF:1.500(Q3/7D).
01/02/2025
The Role of the Norway Rat, Rattus norvegicus, as a Reservoir of Zoonotic Helminth Species in the City of Barcelona (Spain)
Fuentes, MV, Puchades-Colera, P, Gosálvez, C, Sáez-Durán, S, Cholvi-Simó, M, Ruvira, S, Sanxis-Furió, J, Pascual, J, Bueno-Marí, R, Franco, S, Peracho, V, Montalvo, T, Trelis, M, Debenedetti, AL, Galán-Puchades, MT. The Role of the Norway Rat, Rattus norvegicus, as a Reservoir of Zoonotic Helminth Species in the City of Barcelona (Spain). Animals. 2025; 15(3)DOI:10.3390/ani15030298. PMID:39943068. IF:2.700(Q1/2D).
01/02/2025
Characterization of plastic ingestion in urban gull chicks and its implications for their use as pollution sentinels in coastal cities
Max, A, Martín-Vélez, V, Navarro, J, Borrell, A, Montalvo, T, Garcia-Garin, O. Characterization of plastic ingestion in urban gull chicks and its implications for their use as pollution sentinels in coastal cities. MARINE POLLUTION BULLETIN. 2025; 211DOI:10.1016/j.marpolbul.2024.117409. PMID:39667134. IF:4.900(Q1/1D).
01/02/2025
Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations
Godoy, S, Alsedà, M, Parrón, I, Millet, JP, Cayla, JA, Follia, N, Carol, M, Orcau, A, Toledo, D, Ferrus, G, Plans, P, Barrabeig, I, Clotet, L, Domínguez, A, March-Llanes, J, Godoy, P. Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations. Pathogens. 2025; 14(2)DOI:10.3390/pathogens14020175. PMID:40005550. IF:3.300(Q2/5D).
01/02/2025
Is living close to a drug treatment centre associated with stigma?
Bartoll-Roca, X, Barbaglia, MG, Puigdomènech, E, Clotas, C, Bartroli, M, Pérez, K. Is living close to a drug treatment centre associated with stigma?. INTERNATIONAL JOURNAL OF DRUG POLICY. 2025; 136DOI:10.1016/j.drugpo.2025.104707. PMID:39842389. IF:4.400(Q1/1D).